XOMA Royalty Corp (XOMA)

↓ Download CSV

CIK 0000791908 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

In fiscal 2025, XOMA Royalty Corp reported revenue of $52.15M, up 83.1% from the prior year. The company was profitable, with a net margin of 60.8%. It held $272.70M in total assets against $168.74M in total liabilities.

Key ratios (FY2025)

21.8%
Operating margin
60.8%
Net margin
37.8%
Return on equity
+83.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$52.15M$28.49M$4.76M$6.03M$38.16M$29.39M$18.37M$5.30M$52.69M$5.56M
Operating Income$11.38M-$39.98M-$41.85M-$17.41M$17.53M$12.42M-$3.88M-$16.86M$17.03M-$61.56M
Net Income$31.71M-$13.82M-$40.83M-$17.10M$15.80M$13.30M-$1.98M-$13.34M$14.60M-$53.53M
EPS (Diluted)$1.46$-1.65$-4.04$-1.98$0.65$0.78$-0.23$-1.59$0.73$-8.89
Total Assets$272.70M$221.28M$234.30M$140.38M$166.56M$125.28M$95.72M$63.78M$44.94M$28.68M
Total Liabilities$168.74M$139.36M$145.58M$16.37M$24.69M$38.86M$51.74M$45.00M$39.15M$75.89M
Shareholders' Equity$83.94M$61.90M$88.72M$124.01M$141.88M$86.42M$43.99M$18.79M$5.79M-$47.21M
Cash & Equivalents$82.91M$101.65M$153.29M$57.83M$93.33M$45.78M$43.47M$25.74M
Operating Cash Flow$2.87M-$13.75M-$18.16M-$12.88M$22.68M$10.09M-$285.0K-$12.64M$2.69M
Capital Expenditures$98.97M$15.25M
Shares Outstanding17.98M11.70M11.47M11.4K12.19M11.50M8.76M8.37M7.98M6.02M